All 38 SURI (SIMPLIFY PROPEL OPPORTUNITIES ETF) Holdings
There are 38 SURI holdings. Top 10 companies weight: 78.10%.
Total Market Cap: $29B
Rank | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Average | (38 stocks) | -5.58% | 44.14 | 16.50 | 0.80 | +132.17% | +8.67% | 0.96 | ||||||||||
1 | PAGP | Plains Gp Holdings Lp Class A | 40.10% | $24.90 | $5.57B | Oil & Gas Midstream | Energy | N/A | 112.74 | 15.15 | 0.70 | N/A | N/A | 53 | -5.34% | $24 | +24.90% | 0.52 |
2 | ACHV | Achieve Life Sciences Inc | 8.50% | $5.03 | $174M | Biotechnology | Healthcare | -20.82% | N/A | 35.34 | N/A | N/A | N/A | 81 | +160.64% | $13 | -9.96% | N/A |
3 | MIST | Milestone Pharmaceuticals Inc | 8.20% | $1.32 | $165M | Biotechnology | Healthcare | -14.90% | N/A | N/A | N/A | N/A | N/A | 75 | +379.55% | $6.33 | -24.80% | 1.50 |
4 | PHAT | Phathom Pharmaceuticals Inc Ordinary Shares | 4.09% | $9.65 | $853M | Biotechnology | Healthcare | -24.73% | N/A | N/A | N/A | N/A | N/A | 77 | +145.60% | $24 | -21.89% | 1.31 |
5 | DCTH | Delcath Systems Inc | 3.92% | $10.53 | $376M | Medical Devices | Healthcare | N/A | 729.17 | 25.77 | 1.60 | N/A | N/A | 79 | +102.18% | $21 | -1.07% | N/A |
6 | ABEO | Abeona Therapeutics Inc | 3.80% | $5.69 | $324M | Biotechnology | Healthcare | N/A | 4.20 | 526.32 | N/A | N/A | N/A | 75 | +246.40% | $20 | -34.02% | 1.10 |
7 | CLDX | Celldex Therapeutics Inc | 2.60% | $28.90 | $2.11B | Biotechnology | Healthcare | +21.48% | N/A | N/A | N/A | N/A | N/A | 76 | +102.18% | $58 | +0.58% | 1.16 |
8 | CORT | Corcept Therapeutics Inc | 2.52% | $71.20 | $6.96B | Biotechnology | Healthcare | -8.23% | 158.39 | 85.47 | 0.81 | N/A | N/A | N/A | N/A | N/A | +26.78% | N/A |
9 | OCS | Oculis Holding Ag | 2.41% | $12.29 | $1.74B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 81 | +227.75% | $40 | 0.00% | 0.61 |
10 | n/a | Achieve Life Sciences ([wts/rts]) | 1.96% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
11 | n/a | Cash | 1.88% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
12 | LONA | Leonabio Inc | 1.83% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
13 | CMPS | Compass Pathways Plc Adr | 1.74% | $13.33 | $1.60B | Medical Care Facilities | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 78 | +66.54% | $22 | -16.86% | 1.39 |
14 | IVA | Inventiva Sa Adr | 1.61% | $4.09 | $655M | Biotechnology | Healthcare | +24.75% | N/A | N/A | N/A | N/A | N/A | 78 | +269.93% | $15 | -21.19% | 0.74 |
15 | KYTX | Kyverna Therapeutics Inc | 1.57% | $7.90 | $520M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 83 | +284.81% | $30 | 0.00% | 1.78 |
16 | PALI | Palisade Bio Inc | 1.37% | $1.86 | $347M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 82 | +422.04% | $9.71 | -77.24% | N/A |
17 | ZVRA | Zevra Therapeutics Inc | 1.33% | $10.88 | $647M | Biotechnology | Healthcare | N/A | 4.97 | 10.99 | 10.67 | N/A | N/A | 80 | +111.40% | $23 | -0.40% | 0.67 |
18 | AQST | Aquestive Therapeutics Inc | 1.27% | $3.93 | $497M | Drug Manufacturers - Specialty & Generic | Healthcare | -17.65% | N/A | N/A | N/A | N/A | N/A | 80 | +126.21% | $8.89 | +1.16% | 1.40 |
19 | OBIO | Orchestra Biomed Holdings Inc | 1.15% | $3.91 | $232M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 78 | +211.25% | $12 | -17.40% | 1.68 |
20 | n/a | Telesat Canada /telesat Llc 5.625% | 1.15% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
21 | OCUL | Ocular Therapeutix Inc | 1.02% | $8.31 | $1.87B | Biotechnology | Healthcare | -4.26% | N/A | N/A | N/A | N/A | N/A | 84 | +212.88% | $26 | -10.44% | 1.35 |
22 | EYPT | Eyepoint Inc | 0.96% | $12.53 | $1.10B | Biotechnology | Healthcare | +6.42% | N/A | 6.16 | N/A | N/A | N/A | 80 | +195.29% | $37 | +6.37% | 1.30 |
23 | SABS | Sab Biotherapeutics Inc | 0.90% | $3.48 | $273M | Biotechnology | Healthcare | N/A | 14.06 | N/A | N/A | N/A | N/A | 75 | +190.23% | $10 | -48.82% | 0.78 |
24 | TRVI | Trevi Therapeutics Inc | 0.81% | $13.50 | $1.86B | Biotechnology | Healthcare | -27.09% | N/A | N/A | N/A | N/A | N/A | 79 | +77.04% | $24 | +43.35% | 0.64 |
25 | UPB | Upstream Bio Inc | 0.74% | $7.25 | $450M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 78 | +485.24% | $42 | 0.00% | 1.14 |
26 | IMUX | Immunic Inc | 0.64% | $14.64 | $191M | Biotechnology | Healthcare | -24.37% | N/A | N/A | N/A | N/A | N/A | 75 | +205.12% | $45 | -36.55% | 1.25 |
27 | n/a | Akero Therapeutics Inc Cvr | 0.56% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
28 | OVID | Ovid Therapeutics Inc | 0.36% | $2.40 | $425M | Biotechnology | Healthcare | N/A | N/A | 1.79 | N/A | N/A | N/A | 75 | +127.92% | $5.47 | -11.21% | 1.38 |
29 | KLRS | Kalaris Therapeutics Inc | 0.35% | $4.65 | $120M | Biotechnology | Healthcare | -39.47% | N/A | N/A | N/A | N/A | N/A | 78 | +303.23% | $19 | -61.23% | 0.85 |
30 | n/a | Achieve Life Sciences Wts | 0.34% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
31 | ARTV | Artiva Biotherapeutics Inc | 0.32% | $6.87 | $303M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 79 | +421.11% | $36 | 0.00% | 1.53 |
32 | n/a | Altimmune Inc | 0.01% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
33 | n/a | Wts Milestone Pharmaceuticals Inc Series B | 0.01% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
34 | n/a | Contra Chinook Therape & Npv | 0.00% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
35 | n/a | Jasper Therapeutic Wts | 0.00% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
36 | n/a | Eiger Biopharmaceuticals Inc | 0.00% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
37 | n/a | Wts Quoin Pharmaceuticals Ltd Series H | 0.00% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
38 | n/a | Wts Tenaya Therapeutics Inc | 0.00% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
SURI (SIMPLIFY PROPEL OPPORTUNITIES ETF) Sector Allocation
HEALTHCARE
40.10%ENERGY
40.10%INFORMATION TECHNOLOGY
0.00%COMMUNICATION SERVICES
0.00%CONSUMER DISCRETIONARY
0.00%CONSUMER STAPLES
0.00%INDUSTRIALS
0.00%MATERIALS
0.00%UTILITIES
0.00%FINANCIALS
0.00%REAL ESTATE
0.00%